Clinical trial
A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the…
NCT00269724 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00269724 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence |
| Official title | Open-Label Safety And Dose Conversion/Determination Study of OROS® Oxybutynin Chloride for Urge Urinary Incontinence |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Drug |
| Interventions | OROS® oxybutynin |
| Enrollment | 250 |
| Start date | Mar 1, 1997 |
| Completion | Sep 1, 1997 |
| First posted | Dec 26, 2005 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: